Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
Express Scripts
Argus Health
Accenture
Johnson and Johnson
Medtronic
Federal Trade Commission
Fish and Richardson

Generated: November 16, 2018

DrugPatentWatch Database Preview

Leo Pharma As Company Profile

« Back to Dashboard

What is the competitive landscape for LEO PHARMA AS, and when can generic versions of LEO PHARMA AS drugs launch?

LEO PHARMA AS has ten approved drugs.

There are twelve US patents protecting LEO PHARMA AS drugs.

Summary for Leo Pharma As
US Patents:12
Tradenames:7
Ingredients:7
NDAs:10
Drug Master File Entries: 7

Drugs and US Patents for Leo Pharma As

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leo Pharma As DESONATE desonide GEL;TOPICAL 021844-001 Oct 20, 2006 RX Yes Yes 6,387,383 ➤ Sign Up Y Y ➤ Sign Up
Leo Pharma As FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes 8,722,021 ➤ Sign Up Y ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes 6,753,013 ➤ Sign Up Y ➤ Sign Up
Leo Pharma As PROTOPIC tacrolimus OINTMENT;TOPICAL 050777-001 Dec 8, 2000 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Leo Pharma As ENSTILAR betamethasone dipropionate; calcipotriene AEROSOL, FOAM;TOPICAL 207589-001 Oct 16, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Leo Pharma As

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As PROTOPIC tacrolimus OINTMENT;TOPICAL 050777-001 Dec 8, 2000 5,665,727 ➤ Sign Up
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 4,866,048 ➤ Sign Up
Leo Pharma As FINACEA azelaic acid GEL;TOPICAL 021470-001 Dec 24, 2002 4,713,394 ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RE39706 ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 021852-001 Jan 9, 2006 4,866,048 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for LEO PHARMA AS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Ointment 0.03% ➤ Subscribe 2010-11-22
➤ Subscribe Gel 15% ➤ Subscribe 2012-07-27
➤ Subscribe Topical Solution 0.01% ➤ Subscribe 2006-05-19
➤ Subscribe Ointment 0.1% ➤ Subscribe 2010-09-09
➤ Subscribe Ointment 0.005%/0.064% ➤ Subscribe 2010-03-31
➤ Subscribe Topical Foam 15% ➤ Subscribe 2017-09-14
➤ Subscribe Gel 0.05% ➤ Subscribe 2010-12-01

Supplementary Protection Certificates for Leo Pharma As Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
13/044 Ireland ➤ Sign Up PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
2013025 Lithuania ➤ Sign Up PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
2013025,C1304992 Lithuania ➤ Sign Up PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
00617 Netherlands ➤ Sign Up PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
2013 00053 Denmark ➤ Sign Up PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Teva
Farmers Insurance
Julphar
Boehringer Ingelheim
Fish and Richardson
Covington
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.